Merrithew & Thorsten’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Merrithew & Thorsten's DGX Position: Q3 2026 in Review
Merrithew & Thorsten sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 1,748 shares — an estimated $370K sold.
Merrithew & Thorsten first reported a position in DGX in Q4 2025 and held it in 3 quarters. The position peaked at $370K in Q2 2026. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Merrithew & Thorsten reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
- Merrithew & Thorsten sold 1,748 Quest Diagnostics shares in Q3 2026, an estimated $370K.
- Merrithew & Thorsten first reported a position in Quest Diagnostics in Q4 2025 and held it in 3 quarters.
- Merrithew & Thorsten's Quest Diagnostics position peaked at $370K in Q2 2026.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.